222 related articles for article (PubMed ID: 27527805)
1. Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular Cancer.
Nayan M; Jewett MA; Hosni A; Anson-Cartwright L; Bedard PL; Moore M; Hansen AR; Chung P; Warde P; Sweet J; O'Malley M; Atenafu EG; Hamilton RJ
Eur Urol; 2017 Jan; 71(1):120-127. PubMed ID: 27527805
[TBL] [Abstract][Full Text] [Related]
2. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.
Kollmannsberger C; Tandstad T; Bedard PL; Cohn-Cedermark G; Chung PW; Jewett MA; Powles T; Warde PR; Daneshmand S; Protheroe A; Tyldesley S; Black PC; Chi K; So AI; Moore MJ; Nichols CR
J Clin Oncol; 2015 Jan; 33(1):51-7. PubMed ID: 25135991
[TBL] [Abstract][Full Text] [Related]
3. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
Boormans JL; Sylvester R; Anson-Cartwright L; Glicksman RM; Hamilton RJ; Hahn E; Daugaard G; Lauritsen J; Wagner T; Avuzzi B; Nicolai N; Del Muro XG; Aparicio J; Stalder O; Rothermundt C; Fischer S; Laguna MP
Eur Urol Oncol; 2024 Jun; 7(3):537-543. PubMed ID: 37951820
[TBL] [Abstract][Full Text] [Related]
5. Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors.
Li X; Guo S; Wu Z; Dong P; Li Y; Zhang Z; Yao K; Han H; Qin Z; Zhou F; Liu Z
World J Urol; 2015 Sep; 33(9):1351-7. PubMed ID: 25471669
[TBL] [Abstract][Full Text] [Related]
6. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
[TBL] [Abstract][Full Text] [Related]
7. Conditional risk of relapse in patients with germ cell testicular tumors: personalizing surveillance in clinical stage 1 disease.
Goldberg H; Madhur N; Hamilton RJ
Curr Opin Urol; 2018 Sep; 28(5):454-460. PubMed ID: 29916845
[TBL] [Abstract][Full Text] [Related]
8. Late Relapses in Stage I Testicular Cancer Patients on Surveillance.
Mortensen MS; Lauritsen J; Kier MG; Bandak M; Appelt AL; Agerbæk M; Holm NV; Kempel MM; von der Maase H; Daugaard G
Eur Urol; 2016 Aug; 70(2):365-71. PubMed ID: 26996661
[TBL] [Abstract][Full Text] [Related]
9. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
[TBL] [Abstract][Full Text] [Related]
10. A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G
Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686
[TBL] [Abstract][Full Text] [Related]
11. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era.
Yuasa T; Inoshita N; Tanaka H; Urakami S; Yamamoto S; Fujii Y; Masuda H; Fukui I; Ishikawa Y; Yonese J
Int J Clin Oncol; 2015 Dec; 20(6):1198-202. PubMed ID: 25893862
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
[TBL] [Abstract][Full Text] [Related]
13. Surveillance following orchiectomy for stage I testicular seminoma: long-term outcome.
Yoshida T; Kakimoto K; Takezawa K; Arai Y; Ono Y; Meguro N; Kinouchi T; Nishimura K; Usami M
Int J Urol; 2009 Sep; 16(9):756-9. PubMed ID: 19659679
[TBL] [Abstract][Full Text] [Related]
14. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
Lobo J; Leão R; Gillis AJM; van den Berg A; Anson-Cartwright L; Atenafu EG; Kuhathaas K; Chung P; Hansen A; Bedard PL; Jewett MAS; Warde P; O'Malley M; Sweet J; Looijenga LHJ; Hamilton RJ
Eur Urol Oncol; 2021 Jun; 4(3):483-491. PubMed ID: 33288479
[TBL] [Abstract][Full Text] [Related]
15. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
16. Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options.
Francis R; Bower M; Brunström G; Holden L; Newlands ES; Rustin GJ; Seckl MJ
Eur J Cancer; 2000 Oct; 36(15):1925-32. PubMed ID: 11000572
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study.
Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Carus A; Rosenvilde JJ; Berney D; Daugaard G
Eur J Cancer; 2024 May; 202():114025. PubMed ID: 38531266
[TBL] [Abstract][Full Text] [Related]
18. Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer.
Escudero-Ávila R; Rodríguez-Castaño JD; Osman I; Fernandez F; Medina R; Vargas B; Japón-Rodríguez M; Sancho P; Perez-Valderrama B; Praena-Fernández JM; Duran I
Clin Transl Oncol; 2019 Jun; 21(6):796-804. PubMed ID: 30470992
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
[TBL] [Abstract][Full Text] [Related]
20. Management of Clinical Stage I Nonseminomatous Germ Cell Testicular Tumors: A 25-year Single-center Experience.
Ondrusova M; Waczulikova I; Lehotska V; Zeleny T; Ondrus D
Clin Genitourin Cancer; 2017 Dec; 15(6):e1015-e1019. PubMed ID: 28673797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
